Short Communication
Chromosomal location of blaCTX-M genes in clinical isolates of Escherichia coli from Germany, The Netherlands and the UK

https://doi.org/10.1016/j.ijantimicag.2014.02.019Get rights and content

Abstract

This study aimed to detect and characterise clinical Escherichia coli isolates suspected of carrying chromosomally encoded CTX-M enzymes. Escherichia coli (n = 356) obtained in Germany, The Netherlands and the UK (2005–2009) and resistant to third-generation cephalosporins were analysed for the presence of ESBL-/AmpC-encoding genes within the European SAFEFOODERA-ESBL project. β-Lactamases and their association with IS26 and ISEcp1 were investigated by PCR. Isolates were typed by phylogenetic grouping, MLST and PFGE. Plasmids were visualised by S1 nuclease PFGE, and the location of blaCTX-M genes was determined by Southern hybridisation of XbaI-, S1- and I-CeuI-digested DNA. ESBL enzymes could not be located on plasmids in 17/356 isolates (4.8%). These 17 isolates, from different countries and years, were ascribed to phylogenetic groups D (9), B2 (6) and B1 (2), and to seven sequence types, with ST38 being the most frequent (7 phylogroup D isolates). Eleven isolates produced CTX-M-15. blaCTX-M-15 genes were associated with ISEcp1. The remaining isolates expressed the CTX-M group 9 β-lactamases CTX-M-14 (4), CTX-M-9 (1) and CTX-M-51 (1). blaCTX-M probes hybridised with I-CeuI- and/or XbaI-digested DNA, but not with S1-digested DNA, corroborating their chromosomal location. To summarise, only 4.8% of a large collection of ESBL-producing E. coli isolates harboured chromosomal blaCTX-M genes. These isolates were of human origin and belonged predominantly to ST38 and ST131, which possibly indicates the role of these sequence types in this phenomenon. However, heterogeneity among isolates was found, suggesting that their spread is not only due to the dispersion of successful E. coli clones.

Introduction

Production of β-lactamases is the main mechanism responsible for resistance to β-lactams in Enterobacteriaceae. Extended-spectrum β-lactamases (ESBLs) are able to hydrolyse third- and fourth-generation cephalosporins and monobactams, limiting therapeutic options in serious infections caused by Enterobacteriaceae. Over the last decade, the number of ESBL-producing bacteria has increased in many different genera of Enterobacteriaceae and represents a public health threat [1].

CTX-M-type ESBLs are a complex and heterogeneous family of enzymes and may be subdivided into five major groups (CTX-M-1, CTX-M-2, CTX-M-8, CTX-M-9 and CTX-M-25 groups) [2]. These enzymes have spread globally and are the most common ESBLs detected in Enterobacteriaceae, not only in hospitals but also in the community, changing the epidemiology of ESBLs. Among the different CTX-M enzymes, CTX-M-15 (belonging to CTX-M group 1) and CTX-M-14 (belonging to CTX-M group 9) are of high relevance because of their ubiquity, being detected not only in humans and animals but also in environmental samples in many different countries [1], [2]. The successful spread, diversification and maintenance of CTX-M enzymes is due to a combination of different factors: their association with transposable elements and integrons; the capture of these structures by conjugative plasmids; and their transfer to and maintenance in successful bacterial clones [2]. The latter are typified by Escherichia coli clone O25b-ST131, which is a pandemic, multiresistant and uropathogenic lineage frequently associated with the expression of CTX-M-15 and that has contributed significantly to the worldwide spread of this ESBL [3]. This clone habitually harbours the blaCTX-M-15 gene located on plasmids belonging to the IncF family, typically IncFII or multireplicon FII, FIA and FIB [3].

Despite being predominantly plasmid-mediated enzymes, chromosomally located blaCTX-M genes have also been described [4], [5], [6]. In this case, the chromosomal location does not enhance the spread of the gene but does assist its stabilisation and maintenance in the bacterium. The objective of this study was to seek and characterise clinical E. coli isolates suspected of expressing chromosomally encoded CTX-M enzymes from Germany, The Netherlands and the UK.

Section snippets

Bacterial isolates and detection of β-lactamase-encoding genes

Within the European SAFEFOODERA-ESBL project (EU ERA-Net, Ref. 08176), a total of 629 E. coli isolates were selected from the strain collections of the Animal Health and Veterinary Laboratories Agency (AHVLA, UK), Public Health England (PHE, UK), Central Veterinary Institute (CVI, The Netherlands), Friedrich-Loeffler-Institut (FLI, Germany) and Federal Institute for Risk Assessment (BfR, Germany). All isolates were cefotaxime-non-susceptible [minimum inhibitory concentrations above the

Results and discussion

Attempts to transform ESBL genes into a recipient strain failed repeatedly for only 17 (4.8%) of the 356 E. coli isolates and these were selected to investigate chromosomally encoded ESBLs. Of the 17 isolates, 11 produced CTX-M-15 enzyme, usually in addition to narrow-spectrum β-lactamases such as TEM-1 (5 isolates), OXA-1 (2) or both (2) (Table 1). The remaining six isolates expressed CTX-M group 9 ESBLs; four produced CTX-M-14 (with two co-producing TEM-1), whilst CTX-M-9 and CTX-M-51 ESBLs

Acknowledgments

The authors thank S. Schmoger, B. Baumann, W. Barownick and the NRL-Salm staff for their helpful assistance.

Funding: The Federal Institute for Risk Assessment (BfR) [BfR-45-004; BfR-46-001] and the EU-SAFEFOODERA project EU ERA-Net, Ref. 08176, entitled ‘The role of commensal microflora of animals in the transmission of extended spectrum β-lactamases’. During the experimental execution of this work, IR was a postdoctoral student at the BfR (Berlin, Germany), with a grant from the Fundación

References (15)

  • M. Saladin et al.

    Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals

    FEMS Microbiol Lett

    (2002)
  • A. Carattoli

    Plasmids in Gram negatives: molecular typing of resistance plasmids

    Int J Med Microbiol

    (2011)
  • EFSA Panel on Biological Hazards (BIOHAZ)

    Scientific opinion on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals

    EFSA J

    (2011)
  • R. Cantón et al.

    CTX-M enzymes: origin and diffusion

    Front Microbiol

    (2012)
  • B.A. Rogers et al.

    Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain

    J Antimicrob Chemother

    (2011)
  • T.M. Coque et al.

    Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15

    Emerg Infect Dis

    (2008)
  • J. Kim et al.

    Characterization of IncF plasmids carrying the blaCTX-M-14 gene in clinical isolates of Escherichia coli from Korea

    J Antimicrob Chemother

    (2011)
There are more references available in the full text version of this article.

Cited by (72)

  • Chromosomal integration of bla<inf>CTX-M</inf> genes in diverse Escherichia coli isolates recovered from river water in Japan

    2022, Current Research in Microbial Sciences
    Citation Excerpt :

    ESBL genes are often found on plasmids, which facilitates their horizontal spread (Castanheira et al., 2021). However, some previous studies also detected ESBL genes on chromosomes and suggested that integration of ESBL genes into chromosomes could contribute to the stabilization and maintenance of ESBL genes in the absence of antibiotic selection pressure (Hirai et al., 2013; Nair et al., 2021; Rodriguez et al., 2014). Thus, information on the location (chromosome or plasmid) of ESBL genes is important to predict the mobility and stability of these genes.

  • Dynamics of extended-spectrum cephalosporin-resistant Escherichia coli in pig farms: A longitudinal study

    2021, International Journal of Antimicrobial Agents
    Citation Excerpt :

    Interestingly, using long-read sequencing, this study identified two human ST-131 isolates for which the CTX-M-24 gene was inserted in the chromosome. Chromosomally inserted CTX-M within isolates of the highly virulent clone ST-131 have been described [32–34]. However, it is believed that a chromosomally inserted CTX-M-24 gene within ST-131 has so far not been reported.

View all citing articles on Scopus
1

This consortium also includes: Martin J. Woodward and Nick Coldham, Animal Health and Veterinary Laboratories Agency (AHVLA), UK; Kristina Kadlec and Stefan Schwarz, Friedrich-Loeffler-Institut (FLI), Germany; John Threlfall, Neil Woodford and John Wain, Public Health England (PHE), UK; and Cindy Dierikx, Central Veterinary Institute (CVI), The Netherlands.

View full text